4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-036798
Director sold 11,064 shares at an average $18.68 ($206,701)
- Director acquired 39,094 shares (option exercise)
- Director gave up 6,418 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HOLLER FRANK A Director | 2021-05-27 | Option exercise | +3,086 | $3.76 | $11,603 | 125,127 | D: show line 1 in the form |
| HOLLER FRANK A Director | 2021-05-27 | Shares withheld for taxes | −507 | $18.88 | $9,572 | 124,620 | D: show line 2 in the form |
| HOLLER FRANK A Director | 2021-05-27 | Option exercise | +36,008 | $3.76 | $135,390 | 160,628 | D: show line 3 in the form |
| HOLLER FRANK A Director | 2021-05-27 | Shares withheld for taxes | −5,911 | $18.88 | $111,600 | 154,717 | D: show line 4 in the form |
| HOLLER FRANK A Director | 2021-05-27 | Sale | −2,579 | $18.69 | $48,202 | 152,138 | D: show line 5 in the form |
| HOLLER FRANK A Director | 2021-05-27 | Sale | −8,485 | $18.68 | $158,500 | 143,653 | D: show line 6 in the form |
| Open-market sales · 11,064 sh · avg $18.68 · $206,701 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| HOLLER FRANK A Director | 2021-05-27 | Option exercise · Stock Option (Right to Buy) | −3,086 | 0 | D: show line 7 in the form | |||||
| HOLLER FRANK A Director | 2021-05-27 | Option exercise · Stock Option (Right to Buy) | −36,008 | 0 | D: show line 8 in the form |
Loading xslF345X03/doc4.xml…